SHENZHEN, China, March 4, 2013 /PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its fourth quarter and fiscal year 2012 financial results on Thursday, March 28, 2013 before the market opens.
The Company will host a conference call, to be simultaneously webcasted, on Thursday, March 28, 2013 at 8:00 a.m. Eastern Time / 8:00 p.m. Beijing Time. Interested parties may participate in the conference call by dialing +1-877-407-9210 ( North America) or +1-201-689-8049 (International) approximately five minutes before the call start time. A live web cast of the conference call will be available on the China Nepstar website at www.nepstar.cn.
A replay of the call will be available shortly after the conclusion of the conference call through
April 4, 2013 at
11:59 p.m. Eastern Time or
April 5, 2013 at
11:59 a.m. Beijing Time. An archived Web cast of the conference call will be available on the China Nepstar website at
http://www.nepstar.cn. Interested parties may access the replay by dialing +1-877-660-6853 (
North America) or +1-201-612-7415 (International) and entering conference ID number 409876.
About China Nepstar Chain Drugstore Ltd.
China Nepstar is
China's largest retail drugstore chain based on the number of directly operated stores. As of
December 31, 2012, the Company had 2,132 stores across 73 cities, one headquarter distribution center and 16 regional distribution centers in
China. China Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. China Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in
China and to take advantage of the demographic trend in
China to achieve a strong brand and leading market position. For further information, please go to